Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6649)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2015 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Scaffaro LA, Stella SF, Alvares-Da-Silva MR, Kruel CDP. Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma. World J Hepatol 2015; 7(3): 628-632 [PMID: 25848487 DOI: 10.4254/wjh.v7.i3.628] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/628.htm |
| Number | Citing Articles |
| 1 |
Norifumi Harimoto, Mariko Tsukagoshi, Takaomi Seki, Kouki Hoshino, Kei Hagiwara, Norihiro Ishii, Takamichi Igarashi, Kenichiro Araki, Koichiro Haruki, Toru Ikegami, Ken Shirabe. Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC. International Journal of Clinical Oncology 2024; 29(2): 195 doi: 10.1007/s10147-023-02434-7
|
| 2 |
Peng-Sheng Yi, Jun-Ning Liu, Yong Li, Bin Wu, Jian-Shui Li. The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experience. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.920976
|
| 3 |
Pablo Lozano Lominchar, Maitane Igone Orue-Echebarria, Lorena Martín, Cristina Julia Lisbona, María Magdalena Salcedo, Luis Olmedilla, Hemant Sharma, Jose Manuel Asencio, José Ángel López-Baena. Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort study. World Journal of Hepatology 2019; 11(9): 689-700 doi: 10.4254/wjh.v11.i9.689
|
| 4 |
Hsin-Yeh Chen, Kwong-Ming Kee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Yuan-Hung Kuo. Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization. Journal of the Formosan Medical Association 2022; 121(4): 778 doi: 10.1016/j.jfma.2021.07.003
|
| 5 |
D. J. Pinato, J. Howell, R. Ramaswami, R. Sharma. Review article: delivering precision oncology in intermediate‐stage liver cancer. Alimentary Pharmacology & Therapeutics 2017; 45(12): 1514 doi: 10.1111/apt.14066
|
| 6 |
Wen-xin Wei, Zhi-shi Yang, Li-hua Lu, Jun Li, Zheng-qing Lei, Kui Wang, Yong Xia, Zhen-lin Yan, Feng Shen. Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma. International Journal of Surgery 2018; 56: 256 doi: 10.1016/j.ijsu.2018.06.020
|
| 7 |
Ryosuke Kasuga, Nobuhito Taniki, Po-Sung Chu, Masashi Tamura, Takaya Tabuchi, Akihiro Yamaguchi, Shigeo Hayatsu, Jun Koizumi, Keisuke Ojiro, Hitomi Hoshi, Fumihiko Kaneko, Rei Morikawa, Fumie Noguchi, Karin Yamataka, Shingo Usui, Hirotoshi Ebinuma, Osamu Itano, Yasushi Hasegawa, Yuta Abe, Minoru Kitago, Masanori Inoue, Seishi Nakatsuka, Masahiro Jinzaki, Yuko Kitagawa, Takanori Kanai, Nobuhiro Nakamoto. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61611-4
|
| 8 |
Larisse Longo, Laura B. Rodrigues de Freitas, Deivid Santos, Ivana Grivicich, Mário R. Álvares-da-Silva. BCLC-B Subclassification and the Hong Kong Liver Cancer System in Intermediate Hepatocellular Carcinoma. American Journal of Clinical Oncology 2019; 42(5): 466 doi: 10.1097/COC.0000000000000539
|
| 9 |
Peng-Sheng Yi, Hong Wang, Jian-Shui Li. Evolution and current status of the subclassification of intermediate hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2020; 12(3): 85-92 doi: 10.4240/wjgs.v12.i3.85
|
| 10 |
Fengping Jiao, Lu Long, Shanlong Ding, Xiaomeng Xie, Le Jia, Fengmin Lu. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC. Microbial Pathogenesis 2017; 109: 49 doi: 10.1016/j.micpath.2017.04.028
|
| 11 |
Masatoshi Kudo, Tadaaki Arizumi, Kazuomi Ueshima, Toshiharu Sakurai, Masayuki Kitano, Naoshi Nishida. Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria). Digestive Diseases 2015; 33(6): 751 doi: 10.1159/000439290
|
| 12 |
Leandro Armani Scaffaro, Cleber Dario Pinto Kruel, Steffan Frosi Stella, Gabriela Leal Gravina, Geraldo Machado Filho, Carlos Podalirio Borges de Almeida, Luiz Cezar Pontes Fonseca Pinto, Mario Reis Alvares-da-Silva, Cleber Rosito Pinto Kruel. Transarterial Embolization for Hepatocellular Carcinoma: A Comparison between Nonspherical PVA and Microspheres. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/435120
|
| 13 |
Alberta Cappelli, Paloma Sangro, Cristina Mosconi, Iris Deppe, Eleonora Terzi, Jose I. Bilbao, Macarena Rodriguez-Fraile, Caterina De Benedittis, Jens Ricke, Rita Golfieri, Bruno Sangro. Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage. European Journal of Nuclear Medicine and Molecular Imaging 2019; 46(3): 661 doi: 10.1007/s00259-018-4152-7
|
| 14 |
Philip Vutien, Nicole J. Kim, Mindie H. Nguyen. The Diagnosis and Staging of Hepatocellular Carcinoma. Clinics in Liver Disease 2024; doi: 10.1016/j.cld.2024.08.007
|
| 15 |
Sangheun Lee, Beom Kyung Kim, Kijun Song, Jun Yong Park, Sang Hoon Ahn, Seung Up Kim, Kwang‐Hyub Han, Do Young Kim. Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database. Journal of Gastroenterology and Hepatology 2016; 31(4): 842 doi: 10.1111/jgh.13218
|
| 16 |
Ian JY Wee, Fiona NN Moe, Rehena Sultana, Reiko WT Ang, Pearly PS Quek, Brian Kim Poh Goh, Chung Yip Chan, Peng Chung Cheow, Alexander YF Chung, Prema Raj Jeyaraj, Ye Xin Koh, Peter OP Mack, London Lucien PJ Ooi, Ek Khoon Tan, Jin Yao Teo, Juinn Huar Kam, Jacelyn SS Chua, Ashley WY Ng, Jade SQ Goh, Pierce KH Chow. Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System. Journal of Hepatocellular Carcinoma 2022; : 839 doi: 10.2147/JHC.S370212
|
| 17 |
Ruyu Han, Leijuan Gan, Mengran Lang, Guangtao Li, Lu Chen, Xindi Tian, Kangwei Zhu, Liyu Sun, Tianqiang Song. A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy. Journal of Hepatocellular Carcinoma 2024; : 51 doi: 10.2147/JHC.S449441
|
| 18 |
David Prince, Ken Liu, Weiqi Xu, Minjiang Chen, Jin-Yu Sun, Xiao-Jie Lu, Jiansong Ji. Management of patients with intermediate stage hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920970840
|
| 19 |
Wei Xu, Quan Rao, Yongbo An, Mengyi Li, Gang Xu, Xinting Sang, Xin Lu, Zhongtao Zhang, Yilei Mao. Proposal for subclassification to select patients for hepatectomy with intermediate hepatocellular carcinoma and Child–Pugh A liver function. Medicine 2018; 97(32): e11800 doi: 10.1097/MD.0000000000011800
|
| 20 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|